PepGen Inc

About PepGen Inc

PepGen is a biotechnology company focused on transforming the treatment of neuromuscular and neurological diseases through its proprietary Enhanced Delivery Oligonucleotide (EDO) platform. The company aims to develop disease-modifying therapies that safely and effectively target the root cause of serious genetic conditions.

Products & Services

Enhanced Delivery Oligonucleotide (EDO) Platform:A proprietary platform for creating disease-modifying therapeutics targeting the root cause of serious genetic neuromuscular and neurological diseases.

Pipeline Therapies:A range of transformative therapies in development for treating neuromuscular and neurological diseases.

Specialties

Neuromuscular Diseases Neurological Diseases Genetic Therapies Enhanced Delivery Oligonucleotide (EDO) Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 115000000 MR: - FA: $115 million FAN: 115000000	D: 2025-09-26 FD: 2025-09-26	2 investors
2	RT: Public Offering T: - FT: Public Offering	A: 100000000 MR: - FA: $100 million FAN: 100000000	D: 2025-09-24 FD: 2025-09-24	2 investors
3	RT: Underwritten Offering T: - FT: Underwritten Offering	A: 80100000 MR: - FA: 80.1 million FAN: 80100000	D: 2024-02-07 FD: 2024-02-07	10 investors

Public Offering Latest

2025-09-26

$115.0M

2 investors (Pro only)

Public Offering 2025-09-24

$100.0M

Underwritten Offering 2024-02-07

$80.1M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

James McArthur

President and Chief Executive Officer

N

Noel Donnelly

Chief Financial Officer

K

Kasra Kasraian

Chief Technology Officer

P

Paul Streck

Executive Vice President, Head of Research & Development

A

Afsaneh Mohebbi

Senior Vice President, Portfolio and Program Management

H

Hayley Parker

Senior Vice President, Global Regulatory Affairs

View 30 more team members with Pro

Unlock Full Team Directory

Recent News

PepGen Inc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised